文献速递血脂与心血管预防冠心病

膳食欧米伽-6脂肪酸生物标志物与心血管疾病及死亡风险

Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality.
PubMed 文献 · Circulation · 2019-01-01

结果显示较高的LA水平与总心血管疾病、心血管死亡及缺血性卒中风险降低相关,AA水平未增加风险,提示LA对心血管预防可能有益。

要点

  • 较高的循环及组织LA水平与总心血管疾病、心血管死亡和缺血性卒中风险降低相关。
  • AA水平与心血管结局风险升高无关,极端五分位比较中较高AA与总心血管疾病风险降低相关。
  • 结果支持LA在心血管疾病预防中可能发挥有利作用。

核心结论

  • 较高的体内循环及组织LA水平与主要心血管事件风险降低相关,AA可能也相关,支持LA对心血管预防有益。

主要发现

  • LA每跨五分位间距的风险比:总心血管疾病0.93(95%CI 0.88-0.99),心血管死亡0.78(0.70-0.85),缺血性卒中0.88(0.79-0.98),冠心病0.94(0.88-1.00)不显著。
  • AA极端五分位比较:较高水平与总心血管疾病风险降低相关(0.92;95%CI 0.86-0.99),未与心血管结局风险升高相关。
  • 未发现按年龄、性别、种族、糖尿病、他汀使用、阿司匹林使用、欧米伽-3水平或FADS1基因型的一致异质性。

临床怎么用

  • 临床可参考该结果,将较高LA水平视为心血管风险降低的相关标志,但不建议据此直接改变膳食推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Global dietary recommendations for and cardiovascular effects of linoleic acid, the major dietary omega-6 fatty acid, and its major metabolite, arachidonic acid, remain controversial. To address this uncertainty and inform international recommendations, we evaluated how in vivo circulating and tissue levels of linoleic acid (LA) and arachidonic acid (AA) relate to incident cardiovascular disease (CVD) across multiple international studies. METHODS: We performed harmonized, de novo, individual-level analyses in a global consortium of 30 prospective observational studies from 13 countries. Multivariable-adjusted associations of circulating and adipose tissue LA and AA biomarkers with incident total CVD and subtypes (coronary heart disease, ischemic stroke, cardiovascular mortality) were investigated according to a prespecified analytic plan. Levels of LA and AA, measured as the percentage of total fatty acids, were evaluated linearly according to their interquintile range (ie, the range between the midpoint of the first and fifth quintiles), and categorically by quintiles. Study-specific results were pooled using inverse-variance-weighted meta-analysis. Heterogeneity was explored by age, sex, race, diabetes mellitus, statin use, aspirin use, omega-3 levels, and fatty acid desaturase 1 genotype (when available). RESULTS: In 30 prospective studies with medians of follow-up ranging 2.5 to 31.9 years, 15 198 incident cardiovascular events occurred among 68 659 participants. Higher levels of LA were significantly associated with lower risks of total CVD, cardiovascular mortality, and ischemic stroke, with hazard ratios per interquintile range of 0.93 (95% CI, 0.88-0.99), 0.78 (0.70-0.85), and 0.88 (0.79-0.98), respectively, and nonsignificantly with lower coronary heart disease risk (0.94; 0.88-1.00). Relationships were similar for LA evaluated across quintiles. AA levels were not associated with higher risk of cardiovascular outcomes; in a comparison of extreme quintiles, higher levels were associated with lower risk of total CVD (0.92; 0.86-0.99). No consistent heterogeneity by population subgroups was identified in the observed relationships. CONCLUSIONS: In pooled global analyses, higher in vivo circulating and tissue levels of LA and possibly AA were associated with lower risk of major cardiovascular events. These results support a favorable role for LA in CVD prevention.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Marklund M, Wu JHY, Imamura F, et al. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019. PMID: 30971107. doi:10.1161/CIRCULATIONAHA.118.038908

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。